Shenzhen Hepalink Pharmaceutical Group Co Ltd 2024 Sustainability Report
Company: Shenzhen Hepalink Pharmaceutical Group Co Ltd
Sector: Manufacturing
Country: China
Year: 2024
Type: Sustainability Report
Pages: 62
The report covers the Group's 2024 ESG performance across its Shenzhen and US operations. It reports 51,613.7 tonnes of carbon dioxide equivalent from Scope 1 and Scope 2 emissions and total energy consumption of 162,540.6 kWh in'000s. It also describes employee and community initiatives, including a donation of approximately RMB587,000 to local social welfare institutions.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.